Decreasing Albumin mRNA Expression in Cholangiocarcinomas along the Bile Duct Tree
Pathobiology · 2024
DOI: 10.1159/000538706 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathobiology, 2024. Verfasst von Elisa Albertini und 10 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms, RNA, Messenger, In Situ Hybridization. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
The progressive technologies in albumin in situ hybridization (ISH) changed the routine application and the differential diagnosis of hepatic malignancies in the last years. The aim of the present work was to assess the diagnostic utility of albumin ISH on different cholangiocarcinoma (CCA) subtypes, as well as to assess how albumin production changes along the biliary tree.
Methods
Forty-five CCAs were retrospectively selected: 29 intrahepatic (15 small-duct and 14 large-duct subtypes), 7 perihilar, and 9 extrahepatic. Histology was revised in all cases, and albumin ISH was automatically performed by the RNAscope®.
Results
ISH was always negative in extrahepatic CCAs, only 1 perihilar case was positive, and any positivity was observed in 25/29 (86.2%) intrahepatic CCAs (p < 0.001). Concerning CCA subtypes, mean cell positivity was 38.8 ± 29.8% in small-duct CCAs and 11.4 ± 21.9 in large-duct CCAs, respectively (p = 0.003); 12/15 (80.0%) small-duct and 3/14 (21.4%) large-duct CCAs showed >5% positive cells (p = 0.002; odds ratio 14.7).
Conclusions
The introduction of more sensitive techniques changed the indications for ISH since most small-duct intrahepatic CCAs show diffuse positivity. Albumin positivity decreases from liver periphery to the large ducts, suggesting that ISH can be helpful in the differential diagnosis between small-duct and large-duct CCAs, as well as between intrahepatic large-duct CCAs and metastases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- Department of Biomedical and Neuromotor Sciences, School of Anatomic Pathology, University of Bologna, Bologna, Italy.
- Oncology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Zitieren
APA
Albertini, E., Chillotti, S., Monti, G., Malvi, D., Deserti, M., Degiovanni, A., Palloni, A., Tavolari, S., Brandi, G., D'Errico, A., & Vasuri, F. (2024). Decreasing Albumin mRNA Expression in Cholangiocarcinomas along the Bile Duct Tree. Pathobiology. https://doi.org/10.1159/000538706
Vancouver
Albertini E, Chillotti S, Monti G, Malvi D, Deserti M, Degiovanni A, et al. Decreasing Albumin mRNA Expression in Cholangiocarcinomas along the Bile Duct Tree. Pathobiology. 2024. doi:10.1159/000538706
BibTeX
@article{Albertini2024,
author = {Albertini, Elisa and Chillotti, Stefano and Monti, Giada and Malvi, Deborah and Deserti, Marzia and Degiovanni, Alessio and Palloni, Andrea and Tavolari, Simona and Brandi, Giovanni and D'Errico, Antonia and Vasuri, Francesco},
title = {Decreasing Albumin mRNA Expression in Cholangiocarcinomas along the Bile Duct Tree},
journal = {Pathobiology},
year = {2024},
doi = {10.1159/000538706}
}
EUVIMED